AWM
Altium Wealth Management Portfolio holdings
AUM
$1.39B
This Quarter Return
+6.41%
1 Year Return
-12.44%
3 Year Return
+24.96%
5 Year Return
–
10 Year Return
–
AUM
$1.36B
AUM Growth
+$1.36B
(+9.4%)
Cap. Flow
+$41.6M
Cap. Flow
% of AUM
3.05%
Top 10 Holdings %
Top 10 Hldgs %
53.69%
Holding
388
New
8
Increased
168
Reduced
134
Closed
11
Top Buys
Top Sells
| 1 |
Vanguard S&P 500 ETF
VOO
|
$7M |
| 2 |
SPDR Portfolio S&P 500 Growth ETF
SPYG
|
$895K |
| 3 |
Vanguard S&P 500 Value ETF
VOOV
|
$869K |
| 4 |
Vanguard S&P 500 Growth ETF
VOOG
|
$863K |
| 5 |
Vanguard Value ETF
VTV
|
$673K |
Sector Composition
| 1 | Technology | 8.18% |
| 2 | Financials | 6.51% |
| 3 | Healthcare | 3.47% |
| 4 | Consumer Discretionary | 3.18% |
| 5 | Communication Services | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Marsh & McLennan
MMC
$101B
| $1.38M | 0.1% |
9,819
-311
| -3% | -$43.7K |
|
102
Qualcomm
QCOM
$173B
| $1.37M | 0.1% |
9,580
-48
| -0.5% | -$6.86K |
|
103
Applied Materials
AMAT
$128B
| $1.35M | 0.1% |
9,451
+435
| +5% | +$62K |
|
104
Amgen
AMGN
$155B
| $1.34M | 0.1% |
5,502
-813
| -13% | -$198K |
|
105
Schwab US Large- Cap ETF
SCHX
$59B
| $1.33M | 0.1% |
12,784
| – | – |
|
106
Novartis
NVS
$245B
| $1.25M | 0.09% |
13,718
+3,417
| +33% | +$312K |
|
107
Criteo
CRTO
$1.3B
| $1.25M | 0.09% |
27,634
-2,978
| -10% | -$135K |
|
108
Toyota
TM
$254B
| $1.25M | 0.09% |
7,119
+1,496
| +27% | +$262K |
|
109
Illinois Tool Works
ITW
$77.1B
| $1.21M | 0.09% |
5,408
+203
| +4% | +$45.4K |
|
110
iShares Core S&P 500 ETF
IVV
$662B
| $1.21M | 0.09% |
2,812
-108
| -4% | -$46.4K |
|
111
Eli Lilly
LLY
$657B
| $1.18M | 0.09% |
5,147
+407
| +9% | +$93.4K |
|
112
Toll Brothers
TOL
$13.4B
| $1.15M | 0.08% |
19,940
+279
| +1% | +$16.1K |
|
|
LBAI
113
DELISTED
Lakeland Bancorp Inc
LBAI
| $1.14M | 0.08% |
65,006
-13,608
| -17% | -$238K |
|
114
Bristol-Myers Squibb
BMY
$96B
| $1.12M | 0.08% |
16,788
-2,853
| -15% | -$191K |
|
115
Broadridge
BR
$29.9B
| $1.12M | 0.08% |
6,925
| – | – |
|
|
ABB
116
DELISTED
ABB Ltd.
ABB
| $1.12M | 0.08% |
32,908
+6,627
| +25% | +$225K |
|
117
ASML
ASML
$292B
| $1.11M | 0.08% |
1,611
+244
| +18% | +$169K |
|
118
Intuitive Surgical
ISRG
$170B
| $1.09M | 0.08% |
1,184
+140
| +13% | +$129K |
|
119
Norfolk Southern
NSC
$62.8B
| $1.09M | 0.08% |
4,088
-127
| -3% | -$33.7K |
|
120
Morgan Stanley
MS
$240B
| $1.07M | 0.08% |
11,705
+905
| +8% | +$83K |
|
121
Novo Nordisk
NVO
$251B
| $1.07M | 0.08% |
12,793
+2,597
| +25% | +$218K |
|
122
BP
BP
$90.8B
| $1.07M | 0.08% |
40,535
+1,664
| +4% | +$44K |
|
123
Zoetis
ZTS
$69.3B
| $1.06M | 0.08% |
5,685
+416
| +8% | +$77.5K |
|
124
AstraZeneca
AZN
$248B
| $1.04M | 0.08% |
17,400
+4,428
| +34% | +$265K |
|
125
Brookfield
BN
$98.3B
| $1.04M | 0.08% |
20,342
-60
| -0.3% | -$3.06K |
|